Related by context. All words. (Click for frequent words.) 66 BioForm Medical Inc. 64 BFRM 63 NASDAQ CPEX 63 NASDAQ IMDC 63 BioForm Medical 62 Nasdaq EPCT 61 Candela Corporation 61 NYSE MRX 61 Nasdaq GNLB 60 BioForm 60 Genelabs Technologies Inc. 60 NASDAQ TARG 59 Nasdaq WCRX 59 ZIGO 59 Nasdaq CYCC Nasdaq CYCCP 59 Inc. Nasdaq CVTX 58 NASDAQ CLZR 58 Inc. Nasdaq PHMD 58 commonstock 58 Inc. NYSE MYL 58 Nasdaq CLZR 58 WSE IVX 58 Nasdaq PPCO 58 RADIESSE R 58 NASDAQ GNTA 57 EVVV 57 CORLUX CORT # 57 Pliaglis 57 TO IDENTIFY SUCH FORWARD 57 AMEX ISV 57 lender consents 57 Inc. Nasdaq CRTX 57 OR INFORMATION 57 novel MetAP 2 56 Bioform Medical 56 NASDAQ EPMD 56 please visit www.middlebrookpharma.com 56 Nasdaq ANIK 56 Nasdaq OSCI 56 ALDA assumes 56 AGA Medical stockholders 56 Nasdaq ELOS 56 MURRIETA CA #/#/# 56 Nasdaq IMDC 56 Adamis Pharmaceuticals Corporation 56 Nasdaq ICOS 56 AMEX AOM 56 NASDAQ ARTE 56 VaxGen stockholders 56 Penwest Pharmaceuticals Co. 56 Inc. NASDAQ CVTX 56 PRNewswire FirstCall CV Therapeutics 56 Connetics Corporation 55 Amex VTG NYSE Amex 55 Cardiogenesis Corporation 55 Perlite Canada inc 55 Apex Bioventures 55 OR SIMILAR STATEMENTS ARE 55 Transcept Pharmaceuticals 55 Nasdaq HRLY 55 INAMED 55 Georox Resources Inc. 55 Auxilium Pharma 55 Barrier Therapeutics Inc. 55 dedicated CHAT ROOM 55 Zirgan 55 ARE USED THEY IDENTIFY 55 Anika Therapeutics 55 OMRIX Biopharmaceuticals 55 Indevus Pharma 55 MBMI Closes 55 information Thème s 55 Nasdaq IRSN 55 shares issuable pursuant 55 ISTA Pharmaceuticals Inc. 55 Cadence Pharmaceuticals Inc. 55 please visit www.cpexpharm.com 55 Offerors Commercial applies 55 SHOULD BE READ 55 Neurogen disclaims 54 Soriatane 54 Inc. Nasdaq ZILA 54 OTCBB NXPN Northern 54 nasal calcitonin product 54 Corp. Nasdaq TLCR 54 OCTI 54 Dexilant 54 Reloxin R 54 Medicis MRX 54 Kensey Nash Corporation 54 Stockwire.com CHAT LIVE 54 Eurand NV 54 TRUSTCASH 54 NASDAQ MOGN 54 Wolf Haldenstein Investigating 54 Inc. AMEX OKN 54 Receives NASDAQ 54 CoTherix Inc. 54 Endo Pharmaceuticals NASDAQ ENDP 54 Avaranta 54 Elevess 54 Complete Liquidation 54 CapGen Offering 54 Nastech Pharmaceutical Company 54 Regains Compliance 54 Regeneron Pharma 54 NASDAQ ABPI 54 Consent Revocation Statement 54 DOV Pharmaceutical Inc. 54 Nasdaq Deficiency Notice 53 LVB Acquisition Merger Sub 53 * UNTIL FURTHER 53 Nasdaq MGRM 53 Arana Therapeutics Limited 53 Emisphere Technologies 53 Busulfex 53 Alphatec Holdings Inc. 53 Kosan Biosciences Incorporated 53 Non Brokered Placement 53 Willowstar 53 Medicis NYSE MRX 53 Taglich Brothers Initiates Coverage 53 Receives Shareholder Approval 53 Aumento 53 FRANKFURT A3N ATW 53 Reports Inducement Grants 53 Dycom Investments 53 Merger Transaction 53 Successfully Completes Tender Offer 53 Inc. Nasdaq NHRX 53 Novartis VIRT X 53 Announce Early Termination 53 Graniz Loan 53 Hylaform 53 EURO Ressources 53 Nasdaq LGND 53 ELOS 53 ev3 Inc 53 ADZA 53 NASDAQ XETA 53 Inc. NYSE AGN 53 DYSPORT TM 53 www.medicago.com 53 CreXus Investment Corp. 53 Sanctura XR 53 Board Unanimously Rejects 53 EXPECTED RESULTS MAY INCLUDE 53 GNLB 53 Merz Pharma Group 53 Tutogen Medical 53 Ideation Acquisition Corp. 53 visit www.regenbio.com 52 Esprit Pharma 52 Terminates Merger Agreement 52 Theravance assumes 52 NASDAQ Deficiency Notice 52 Regains NASDAQ 52 Sets Record Date 52 Metabasis stockholders 52 #,#,# warrants exercisable 52 update theseforward looking 52 Inspire Pharmaceuticals ISPH 52 Factual statements contained 52 InKine 52 PAIVIS 52 BCY 52 Nasdaq LTXC 52 underwriting discounts commissions 52 Indevus undertakes 52 convertible promissory notes 52 Orapred ODT 52 Syneron Medical Ltd. 52 SearchHelp communications 52 Pamrapo Bancorp 52 ENGINEERING.com Incorporated Announces 52 Stockholder Approval 52 OcuSense 52 Harbor BioSciences 52 PAIVIS actual 52 InSite Vision Incorporated 52 Medicis Pharmaceutical Corp 52 Biologic License Application BLA 52 Millstream II 52 Polyphenon ® E 52 Allergan NYSE AGN 52 NASDAQ IPXL 52 ReAble 52 EVLN 52 Extends Tender Offer 52 CorePharma LLC 52 Aurvista 52 Oscient Pharmaceuticals 52 visit www.c cor.com 52 Eurand NV EURX 52 Facet Biotech Corporation 52 NASDAQ Listing Qualification 52 Ateba Resources Inc. 52 UNITED STATES SECURITIES ACT 52 Announce Monthly Distributions 52 Amends Tender Offer 52 USPoly 52 Calixa 52 recombinant thrombin 52 Salary.com expressly disclaims 52 Regains Compliance With 51 Sunesis Pharmaceuticals 51 Explores Strategic Alternatives 51 PURPOSE OF SAFE HARBOR 51 Inc. Nasdaq TRMA 51 outstanding Restricted Voting 51 Neurogen stockholders 51 ACTUAL RESULTS MIGHT DIFFER 51 Second Amended 51 Penwest Pharmaceuticals 51 Lumera stockholders 51 XIBROM 51 Initial Purchasers 51 THIS DOCUMENT CONTAINS CERTAIN 51 OFCD Optionally Fully 51 ATW Transaction 51 Amnesteem Claravis 51 OmniComm intends 51 LOI contemplates 51 Iridex 51 Valera Pharmaceuticals 51 Cellu Tissue stockholders 51 Terminate Merger Agreement 51 % Convertible Subordinated 51 AkaRx 51 Omigard TM 51 Unsolicited Proposal From 51 Lifecore Biomedical 51 Galderma SA 51 Medicis Pharma 51 Macrovision assumes 51 Interpore International 51 thispress release 51 Announces Effective Date 51 NASDAQ Hearings Panel 51 NYSE AGN 51 Cornerstone BioPharma Holdings 51 Cobalis Corp 51 Closes Non Brokered 51 TriPath Oncology 51 ATMI undertakes 51 PROVISIONS OF THE PRIVATE 51 Coapt Systems 51 Completes Tender Offer 51 Orthodontix 51 Prism Pharmaceuticals 51 Alphatec Holdings 51 Debentures tendered 51 botulinum toxin Type 51 subsequent amendments thereto 51 AAA FWB ALT 51 T Pred 51 MEEI litigation 51 specify Kirrin News 51 MQ Associates 51 Medicis Pharmaceutical 51 FICO disclaims 51 IntelliPharmaCeutics Ltd. 51 NASDAQ LBTYA NASDAQ LBTYB 51 ABII 51 NSGold Corporation 51 ReAble Therapeutics Inc. 51 update anyforward looking 51 DISMISSED WITH PREJUDICE 51 Proprius Pharmaceuticals 51 Portec undertakes 51 Convera assumes 51 Artes Medical 51 Files Shelf Registration Statement 51 Completes Second Tranche 51 SOLODYN R 51 information visit www.parpharm.com 51 Sanctura 51 ISTA Pharmaceuticals 51 Atrix Laboratories Inc. 51 KYPH 51 Aeroflex stockholders 51 Nasdaq Minimum Bid 51 Ucyclyd Pharma Inc. 50 Extina 50 TVI Subscription Agreement 50 * Potentially libelous 50 Igeneon 50 Announce Shareholder Approval 50 mutually satisfactory definitive 50 Medicis Pharmaceutical Corporation 50 Questcor Pharmaceuticals 50 Nasdaq Hearings Panel 50 PLAYLOGIC assumes 50 Receives Anticipated 50 Stockholders Approve 50 Announces Postponement 50 Inflazyme Pharmaceuticals 50 CLHI 50 Zareba shareholders 50 NSTK 50 Investigates Breach 50 AuthenTec stockholders 50 Tolmar 50 Restoraderm R 50 Diomed disclaims 50 Commences Mailing 50 Obagi Medical Products 50 looking statementsâ € 50 Nasdaq ADRX 50 Nycomed GmbH 50 ticker LUPE 50 On4 Communications Inc. 50 Auxilium assessments 50 Abe Shainberg Esq 50 Shareholders Approve Merger Agreement 50 AMPS Risk 50 Announces Adjournment 50 PLAYLOGIC 50 VeriSign undertakes 50 Graphic Packaging Corporation 50 IV APAP 50 NitroMed stockholders 50 Corporation OTCBB SVUL 50 NASDAQ Minimum Bid 50 Openwave assumes 50 Cephalon NASDAQ CEPH 50 Recommendation Statement 50 Total Consideration minus 50 Inc. OTCBB VIVK 50 visit www.ethosfr.com 50 NASDAQ LBTYK 50 Adjourns Annual Meeting 50 OccuLogix 50 Incentive Compensation Plan 50 Rhein Biotech NV 50 Fortical R 50 revise anyforward looking 50 AcelRx Pharmaceuticals 50 Solta Medical Inc. 50 please visit www.PositiveIDCorp.com 50 Adopts Shareholder Rights 50 IsoTis OrthoBiologics 50 Announces Reverse Split 50 Xphase 50 reflect GuestLogix 50 Contingent Convertible Senior 50 BY MAKING THESE 50 reflecting Achillion 50 visit www.parpharm.com 50 RESTYLANE R 50 Zone4Play undertakes 50 Aegerion Pharmaceuticals Inc. 50 IsoTis SA 50 ORDERED ADJUDGED AND DECREED 50 TSX VENTURE PPY.A TSX 50 consents authorizations 50 Shire NASDAQ SHPGY 50 NOVT 50 historicalfacts 50 IsoTis stockholders 50 FOXH 50 ATK undertakes 50 Cutera Nasdaq CUTR 50 Schefferville Properties 50 Lifecore 50 MedCom USA Inc. 50 Changes Ticker Symbol 50 Exchangeco 50 Caprius 50 Transcept Pharmaceuticals Inc. 50 Merz Pharma 50 Cellegy Pharmaceuticals 50 NQCI 50 NxStage anticipates 50 Laserscope 50 VIOXX Lawsuits 50 Siebel Systems assumes 50 Galderma Pharma SA 50 liquidating distributions 49 Reinhold Industries 49 Preliminary Consent Revocation 49 Announces Revocation 49 Playlogic assumes 49 MELA Sciences Inc. 49 SynthRx 49 Tessera assumes 49 Company undertakes noobligation 49 OTCBB BTEM 49 AltaRex 49 Amalgamation Resolution 49 Stockholder Protection 49 Arotech assumes 49 forward lookingstatement 49 rStar 49 Electro Optical Sciences 49 Micro Therapeutics 49 trading symbol GCKO 49 LOOKING INFORMATION Except 49 NASDAQ TGEN 49 THRM 49 FermaVir 49 Cutanea Life Sciences 49 DISCLOSURE NOTICE 49 Andrx Corporation 49 Somaxon Pharmaceuticals 49 Theforward looking 49 -leukemias 49 Sigmapharm 49 OmniVision expressly disclaims 49 Stock Repurchase Plan 49 X Ceptor 49 SciClone Pharmaceuticals Inc. 49 Ensource 49 Supplemental Indentures 49 XplosiveStocks.com undertakes 49 Amends Terms 49 Minsud 49 Convertible Senior Subordinated 49 Valley Forge Scientific 49 Acknowledges Receipt 49 Medigen 49 PBG undertakes 49 proprietary Capillary Aerosolization Technology 49 visit http:/www.zilog.com/ 49 Jupitermedia assumes 49 DOVP 49 IntraBiotics 49 Congoleum undertakes 49 Definitive Proxy Statement Prospectus 49 FoxHollow Technologies Inc. 49 ZARS Pharma 49 Completes Debt Refinancing 49 Paivis Corp. PINKSHEETS PAVC 49 LogicVision disclaims 49 Merz Aesthetics 49 Velac 49 QuaTech 49 CCU Notes 49 GSI Commerce expressly disclaims 49 mergers dispositions 49 Schedule #C 49 Cognex disclaims 49 Thoma Bravo Merger 49 integrating ADVO operations 49 El.En. 49 Centerplate undertakes 49 Advanced Magnetics 49 Seriatim 49 Medarex disclaims however 49 Merger Agreement dated 49 mPhase assumes 49 OR INFORMATION INVOLVE 49 Atheros disclaims 49 Annual Meeting Date 49 Aesthera Corporation 49 IOMED 49 theseforward looking 49 BioSphere Medical 49 including withoutlimitation 49 symbol HAWK 49 Underwriters Exercise 49 BCSB Bankcorp 49 Cell Pathways 49 FEGR disclaims 49 Shamir Optical 49 Mircette 49 forward lookinginformation 49 ISSUED TO 49 Novacea stockholders 49 Novoste Corporation 49 PDL BioPharma Inc. 49 Stockholders Approve Merger 49 Aimco assumes 49 Claravis 49 vinorelbine emulsion 49 SEC Form #F 49 Nasdaq ETWC 49 NYSE PHH PHH 49 Dificid 49 Orckit assumes 49 Kensey Nash 49 orally disintegrating 49 Wintraysan 49 Possis Medical 49 remaining untendered 49 Announces Stockholder Approval 49 Defined Terms 49 thedate 49 CollaGenex Pharmaceuticals Inc. 49 Listings Qualifications Panel 49 NASDAQ DNBK 49 SOLODYN 49 Oremex Gold 49 visit http:/www.emcore.com 49 Contingent Value Rights 48 Van Kampen Closed End 48 Basic Subscription Privilege 48 JENOPTIK AG 48 Valera Pharmaceuticals Inc. 48 Special Stockholder Meeting 48 TSX VENTURE DOG 48 Receives Stockholder Approval 48 HSR clearance 48 http:/www.camtek.co.il 48 validly tendered Notes 48 SMSC Transaction 48 CardioTech International 48 NitroMed BiDil 48 NRDC Acquisition stockholders 48 Nasdaq OFIX 48 Periostat 48 noncumulative perpetual preferred 48 Adopts Stockholder Rights 48 Sparton assumes 48 Noven Therapeutics 48 CAUTIONARY STATEMENT Statements 48 LeMaitre Vascular 48 EP MedSystems shareholders 48 futureevents 48 symbol TSH 48 Unsecured Debentures 48 Gestiva 48 Connetics disclaims 48 Solta Medical 48 PhosLo 48 BioSpecifics 48 Onyx undertakes 48 Hexion Proposal 48 Idenix anticipates 48 execute supplemental indenture 48 RR Donnelley disclaims 48 RESTASIS R 48 Eurogas International 48 EP MedSystems 48 ADAM disclaims 48 CoStar assumes 48 addition AGC AVK 48 Bentley Pharmaceuticals 48 ATG undertakes 48 Vector Intersect 48 Rozetta Cell 48 Exploring Strategic Alternatives 48 Vaso Active 48 Proxy Statements 48 transactions contemplated 48 Acular 48 Completes Previously Announced 48 Valentis 48 WFWS undertakes 48 aux actionnaires 48 BioDelivery Sciences 48 Rocmec Closes 48 TriNet Notes 48 Trubion stockholders 48 Statement Prospectus 48 ELEVESS 48 Kind Tender Offer 48 Connetics 48 reflect events orcircumstances 48 Registration Statement Declared Effective 48 BioSante undertakes 48 Syneron Medical 48 clopidogrel bisulfate 48 affecting BEO Bancorp 48 ON FORWARD LOOKING 48 Proginet stockholders 48 Biosante Pharmaceuticals 48 Nasdaq WATG 48 d Reflects 48 CV Therapeutics disclaims 48 Compensation Warrants 48 Pharmachem Revised Offer 48 successfully commercialize Silenor 48 HickoryTech undertakes 48 Wavefront expressly disclaims 48 Shareholders Approve Plan 48 MethyPatch 48 Interpore 48 Seabridge cautions 48 B Preferred Stock 48 Ovion 48 TLCVision assumes 48 Crisa acquisition 48 fexofenadine hydrochloride 48 anyforward looking 48 DTLL 48 TomoTherapy judgments 48 BioLife Solutions 48 MAKO Surgical 48 Calpine undertakes 48 Tucows assumes 48 DJ AIGCI Handbook 48 Landsbanki Íslands hf 48 Prevelle Silk 48 Subordinated Note 48 AutoImmune 48 Elestat 48 Vicuron Pharmaceuticals 48 Xenogen Corporation 48 LOPROX R 48 Investus 48 Evaluate Strategic Alternatives 48 Valeant Pharmaceuticals NYSE VRX 48 FairPoint undertakes 48 Nasdaq Notice Regarding 48 Company TSX.V HLS 48 XTENT 48 toreflect 48 FastMarkets Ltd 48 www.medicis.com 48 HSR Waiting Period 48 Confirms Receipt 48 applicable Consent Deadline 48 Sciele Pharma Inc. 48 Cortelco 48 MacroChem 48 Shareholders Approve Proposed 48 DIP Loan 48 Cabot Microelectronics assumes 48 Barrier Therapeutics 48 PLAVIX R patent 48 suchforward looking 48 Resale Registration Statement 48 AVANIR disclaims any 48 Selectica assumes 48 forward.looking statements 48 MIGENIX 48 USBI undertakes 48 Loprox 48 Schiff Nutrition disclaims 48 ImmuneRegen intends 48 Bellwether undertakes 48 Galderma Pharma 48 issuable upon exercise 48 historical facts areforward 48 Perpetual Non Cumulative 48 Craig Tooman 48 Den Mat Holdings 48 Packeteer assumes 48 Accuray ARAY 48 exhibits thereto 48 JDS Pharmaceuticals 48 thisrelease 48 Enpath 48 reflect VIQ Solutions 48 NASDAQ CYBS 48 Lipid Sciences assumes 48 disinterested shareholder 48 Senior Subordinated Secured Notes 48 please email chris@chfir.com 48 Manugistics assumes 48 TSX VENTURE ORM 48 OTCBB CPEU 48 tazarotene 48 Joint Proxy 48 Sucampo Pharmaceuticals anticipates 48 looking statements.Such 48 Electro Scientific 48 Combination Agreement 48 Montaur 48 Immucor assumes 48 Shareholder Approval 48 visit http:/www.parpharm.com/ 47 Tendering holders 47 Underwritten Offering 47 LEXINGTON Mass. Cubist Pharmaceuticals 47 Proposed Financing 47 MacroPore Biosurgery 47 looking statementswithin 47 Safe Harbor Forward Looking 47 Lumenis Ltd. 47 BreitBurn GP LLC 47 Leadis disclaims 47 SAFE HARBOUR 47 CorMedix 47 Nasdaq CCBP 47 ZTEST Announces 47 NASDAQ NTII 47 Repros Therapeutics 47 Completes Merger With 47 Securityholders Approve 47 unsecured subordinated debentures 47 Receives Notification 47 BigString Corporation intends 47 Migenix 47 JHP Pharmaceuticals LLC 47 DJOFL 47 intangible assets imputed 47 Eximias Pharmaceutical Corporation 47 oversubscription privilege 47 undertake anyobligation 47 NovaDel 47 Miraculins cautions 47 Kinetin 47 Acura Pharmaceuticals 47 Elestrin 47 adopting SFAS #R 47 AHGP owns 47 Cell Genesys stockholders 47 GreenHunter Energy undertakes 47 accreted principal 47 AGCO disclaims 47 Tikcro 47 Noven Pharmaceuticals Inc. 47 Restructurings microprocessors 47 ExonHit Therapeutics SA 47 Rexahn assumes 47 Par Pharmaceutical Companies 47 Inc. Nasdaq SLXA 47 Amedia assumes 47 Lidoderm R 47 ARCA Biopharma 47 NASDAQ CHIP VeriChip 47 Debt Settlement Agreements 47 PharmaBio 47 Gruppo Angelini 47 Geac intentions 47 indentures pursuant 47 accordance therewith 47 Orbit assumes 47 Hana Biosciences 47 Cubist Pharmaceuticals Inc. 47 TorreyPines Therapeutics 47 MR Civ 47 share repurchase authorizations 47 CollaGenex Pharmaceuticals 47 Special Shareholder Meeting 47 Curosurf 47 Immersion disclaims 47 BiDil XR drug 47 Nasdaq Listing Requirements 47 Natus disclaims any 47 Perpetual PIERS 47 QLT USA 47 Laurion cautions against 47 Preferred Stockholders 47 Critical Therapeutics 47 BacTech Environmental 47 stockholders definitive proxy 47 Cubist Pharma 47 Consent Letter 47 BioStem Inc. 47 broker warrants exercisable 47 Sepracor anticipates 47 DRAXIS 47 Primedex 47 Spectrum Pharmaceuticals Inc. 47 CAN GENERALLY BE IDENTIFIED 47 Agreement constitutes discloseable 47 Advises Stockholders 47 DELETE OR EDIT COMMENTS 47 Canetic Unitholders 47 Nasdaq Listing Qualification 47 Brokered Placement 47 Dataworks disclaims 47 Solicitation Statement 47 aresubject 47 Intelident 47 Staar Surgical Co. 47 Yucheng assumes 47 Adjourns Special Meeting 47 Reschedules Annual Meeting 47 Hoyoung Huh 47 Ciena assumes 47 Novartis Reclast 47 Debentures validly tendered 47 BlueFire undertakes 47 Juvederm XC 47 customary representations warranties 47 APPY believes 47 Nanometrics disclaims 47 Avanir Pharmaceuticals 47 Furiex Pharmaceuticals 47 accompanying prospectus supplement 47 CAUTIONARY STATEMENT Certain 47 Bonus Warrants 47 Existing Convertible Notes 47 Medicago disclaims 47 Vivus NASDAQ VVUS 47 Investigates Proposed Acquisition 47 Regains Nasdaq 47 Nellix 47 Datascope Corp. 47 SG undertakes 47 Vernalis plc 47 Acquisition Transaction 47 NETM 47 Announces Shareholder Approval 47 visit www.easylink.com 47 expressively disclaims 47 Fancamp Announces 47 Minimum Tender Condition 47 Consent Fees 47 Secured Debentures 47 Second Tranche 47 â € œwill â 47 Loudeye assumes 47 FORWARD LOOKING INFORMATION 47 table reconciles 47 transactions contemplated thereunder 47 Sotret 47 constituteforward looking 47 Legal #.# 47 ZYPS 47 Concurrent Financing 47 AirIQ perception 47 RESTYLANE 47 Financing Condition 47 Rejects Unsolicited 47 Accelerated Expiry Date 47 Seek Shareholder Approval 47 Escrowed Proceeds 47 Proposed Arrangement 47 unexercised warrants 47 debentureholders 47 Rigel Pharmaceuticals 47 Vistior 47 Restylane ® 47 Silicon Image assumes 47 Auxilium Pharmaceuticals 47 Evithrom 47 Form #c# 47 ALICO Holdings 47 visit http:/www.parpharm.com 47 hereby disclaimed 47 Announces Record Date 47 reflect Medicago 47 Calixa Therapeutics 47 Colo. Sess 46 Maxim Pharmaceuticals 46 AMICAS stockholders 46 Momenta Pharmaceuticals 46 ePlus undertakes 46 SAVVIS assumes 46 BioMarin Pharmaceutical 46 nakedness literal 46 Corautus 46 visit http:/www.nexiaholdings.com 46 Efudex 46 discloseable transaction 46 visit www.fronteergroup.com 46 Alphagan 46 NYSE GDT 46 Oncobionic 46 website www.encana.com 46 Halozyme Therapeutics 46 Cerexa Inc. 46 Raven Biotechnologies 46 financialstatements 46 securities issuable pursuant 46 Cougar Biotechnology Inc. 46 Ore Pharmaceuticals 46 Valcent disclaims 46 Bioenvision disclaims any 46 Lincare assumes 46 LenSx 46 Prospectus Proxy Statement 46 Indevus Pharmaceuticals Inc. 46 convertible subordinated debentures 46 Proxy Proposals 46 Cautionary Statements Statements 46 Combigan 46 SenoRx 46 Amylin disclaims 46 attaching thereto 46 ReNvision 46 Warrantholders 46 theCompany 46 Solaraze 46 Existing Debentures 46 Medicis disclaims any 46 Amag 46 Nascobal 46 withrespect 46 Acceptance Priority Levels 46 Trintech Shareholders 46 AMAG Pharmaceuticals Inc. 46 Contingent Value Right 46 Comamtech 46 Applied Energetics undertakes 46 Listing Qualifications Panel 46 Omnibus Incentive Plan 46 Cumulative Perpetual Preferred Stock 46 Chesstown 46 Receives Delisting Notice 46 Definitive Consent Revocation Statement 46 Idera disclaims any 46 Medicis Pharmaceutical Corp. 46 Gralise 46 Reviso 46 EnerCare Solutions 46 ChipMOS Taiwan 46 Akela Pharma 46 Dolby disclaims 46 Hologic NASDAQ HOLX 46 Agile Therapeutics 46 expressly qualifies 46 AUCTIONEER CONSIGNOR OR 46 statements ofhistorical fact 46 Jonah Shacknai Chairman 46 Kilroy Realty LP 46 REMANDED 46 Synalloy Corporation assumes 46 Agria beliefs 46 ViroPharma VPHM 46 Inamed IMDC 46 #,#,# ADSs [001] 46 Aegerion Pharmaceuticals 46 NYSE MNT 46 Retavase 46 Tender Offer Documents 46 Pharmagesic 46 Varvarinskoye Project 46 Staff Determination Letter 46 law ZymoGenetics undertakes 46 Mandatory Convertible Bonds 46 Ardea Biosciences 46 Files Annual Report 46 Inc. Nasdaq NSIT 46 reincorporation merger 46 Restylane Perlane 46 validly surrendered 46 immediately separable 46 HNW trades 46 Angiodynamics 46 Zero Coupon Notes 46 Eraxis 46 Senior Secured Convertible Debentures 46 DOVONEX 46 Altus Pharmaceuticals 46 Leezamax 46 Thermadyne shareholders 46 Miacalcin 46 Shareholders Overwhelmingly Approve 46 Reverse Takeover 46 SPECIAL NOTE REGARDING FORWARD 46 Axonyx 46 MTM Technologies disclaims 46 Largo website www.largoresources.com 46 INDEXPLUS 46 SouthWest Water stockholders 46 SearchMedia cautions readers 46 KV Pharmaceutical Company 46 Increases Share Repurchase 46 Inducement Stock 46 Specifications pricing 46 Abraxis Bioscience 46 EPE unitholders 46 Minimum Bid Price 46 QMLP 46 SmarTire cautions 46 ESBATech AG 46 website www.aeroflex.com 46 PRC Yuhe 46 Signs Binding Agreement 46 nonoccurrence 46 Base Offer Consideration 46 regardingthe 46 Silvercorp Offer 46 TSX EE Exall 46 verbatim extract 46 NanoSensors 46 aEURoeforward looking 46 Orthofix International 46 underwriters overallotment option 46 Metalico assumes 46 repurchase authorizations 46 Savient Pharmaceuticals 46 Virbac SA 46 EPIX Pharmaceuticals 46 AAMAC stockholders 46 Ipsen SA 46 Preliminary Proxy Statement 46 IntelGenx assumes 46 Adjournment Proposal 46 4C Controls undertakes 46 SyntheMed 46 eXegenics 46 Miscellaneous Fares 46 Certifications Commercial 46 IDM Pharma 46 Final Liquidating Distribution 46 reflecting Maximizer Software 46 Mentor silicone gel 46 Escrowed Shares 46 OTCS undertakes 46 Arrangement Resolution 46 Wellco unitholders 46 MNDL 46 Thesestatements 46 Molecular Insight 46 Non Brokered Offering 46 Ista Pharmaceuticals 46 Looking Statements -Dunshaughlin Co Meath 46 Bacterin 46 Cellegy Pharmaceuticals Inc. 46 Ordinary Dividends 46 theSecurities 46 please visit www.memc.com